Follows people with Duchenne muscular dystrophy to track how the disease changes over time
Follows people aged 2 years and older with Duchenne muscular dystrophy over time.
Plain-language title generated from the registry record
Registry title: A Registered Cohort Study on Duchenne Muscular Dystrophy
Key facts
- Where
- Fuzhou, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with Duchenne Muscular Dystrophy, and female carriers, who are older than 2 years. The aim is to follow how the disease develops over time.
- Age
- Older than 2 years (minimum age 2 Years)
- Sex
- All sexes
- Disease stage
- Diagnosis of Duchenne Muscular Dystrophy, or female carrier, confirmed by genetic testing.
- Biomarker or test result
- The diagnosis must be confirmed by genetic testing. If there is no genetic confirmation, a muscle biopsy must support the diagnosis.
Main reasons for not taking part
- Another clinically significant illness
Read by machine on 12 November 2026.
Where in China
- First Affiliated Hospital of Fujian Medical UniversityFuzhou, ChinaContact: Ming Jin, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Ning Wang, MD., PhD.
- Trial code
- NCT04012671
- Record updated
- 22 March 2021
- Original description
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.Read full original descriptionShow less
A Registered Cohort Study on Duchenne Muscular Dystrophy
Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
Inclusion: Beyond 2 years old; Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed; Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
Exclusion: Presence of other clinically significant illness.